A randomised controlled trial of a nurse delivered stage-matched smoking cessation intervention to promote heart health of cardiac patients

ISRCTN ISRCTN32840413
DOI https://doi.org/10.1186/ISRCTN32840413
Protocol serial number N/A
Sponsor The Hong Kong Research Grants Council (RGC) (Hong Kong)
Funder The Hong Kong Research Grants Council (RGC) (Hong Kong) - Earmarked Research Grant 2001-2002 (ref. No: HKU 7224/01M)
Submission date
31/10/2007
Registration date
06/11/2007
Last edited
24/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sophia Siu-chee Chan
Scientific

4/F, William MW Mong Block
Li Ka Shing Faculty of Medicine Building
21 Sassoon Road
Pokfulam
-
Hong Kong

Study information

Primary study designInterventional
Study designA multicentre randomised single-blind placebo controlled study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study objectivesThe nurse delivered stage-matched smoking cessation intervention is to achieve a higher quit rate than the control among Chinese cardiac patients.
Ethics approval(s)Ethics approval received from the New Territories West Cluster Clinical and Research Ethics Committee on the 14th October 2007 (ref: NTWC/CREC/325/04).
Health condition(s) or problem(s) studiedSmoking cessation
InterventionIntervention: duration is 1 month with an initial face-to-face stage-matched smoking cessation counselling at the outpatient clinic (usually last for 2 - 30 minutes), and 10-minute telephone reminders at 1-week and 1-month, totalling in 40 - 50 minutes. The mean counselling times in the intervention group were 21.07 minutes at baseline, 12.70 minutes at 1-week follow up and 13.31 minutes at 1-month follow up.

Control: receive a healthy diet education manual from our study at the outpatient clinic after randomisation. The mean counselling time in the control group was 17.58 minutes.

Subjects in both groups received standard care after hospitalisation from the individual hospital which may be different from hospital to hospital. All the patients were followed up at 3-month, 6-month, and 12-month after initial contact and self-reported quitters were invited to participate in a urine cotinine test.
Intervention typeOther
Primary outcome measure(s)

Continuous abstinence for one month at the time of 3, 6, and 12 month follow up.

Key secondary outcome measure(s)

1. Reduction in the number of cigarette smoked at 3, 6, and 12 months follow up
2. Progression to a higher stage of readiness to quit (5 stages: precontemplation, contemplation, preparation, action, maintenance) at 3, 6, and 12 months follow up

Completion date31/12/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration1824
Key inclusion criteria1. Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalisation
2. Patient speaks and reads Cantonese/Chinese
3. Patient over 18 years, male or female
Key exclusion criteria1. Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention
2. Patient who does not speak or read Chinese
Date of first enrolment06/03/2002
Date of final enrolment31/12/2004

Locations

Countries of recruitment

  • Hong Kong

Study participating centre

4/F, William MW Mong Block
Pokfulam
-
Hong Kong

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes